Zambia Introduces National Medicine Track and Trace System to Stop Theft of Government Drugs

Youth Village Zambia
9 Min Read

The Zambian government has introduced a national medicine track and trace system aimed at stopping the theft, illegal sale and diversion of medicines intended for patients in public health facilities. The initiative, implemented by the Ministry of Health and the Zambia Medicines Regulatory Authority (ZAMRA), will make it possible to track medicine packs from the point they enter the country or leave the factory until they reach the patient. Every pack will carry a security label featuring a unique barcode and serial number to help establish its origin and movement through the supply chain. The system will also help members of the public distinguish between medicines intended for government health facilities and those supplied to private pharmacies. With implementation scheduled to begin on 2 November 2026, the government hopes the new measures will strengthen accountability, protect public resources and improve access to essential medicines across Zambia.

Under the new medicine tracking system, medicines supplied to government health facilities will carry a red security label marked “Property of the Ministry of Health, Not for Sale.” Medicines intended for private pharmacies will carry a blue label, making it easier to distinguish between the two categories. The labels will provide a visible warning against the unauthorised sale of medicines purchased or supplied for public health services. The unique barcode and serial number will also provide identifying information that can help authorities trace individual packs through the medicine distribution network. This approach is designed to make it harder for stolen government medicines to enter private markets without raising suspicion.

The introduction of the national medicine track and trace system comes amid concerns about the loss and diversion of medicines meant for patients receiving treatment at public health facilities. When government medicines are stolen or diverted for private sale, patients can face shortages even when supplies were originally purchased for their needs. Such practices can undermine confidence in public healthcare and place additional pressure on households that may already struggle to afford treatment. A system that records the movement of individual medicine packs could help investigators identify where products were meant to be delivered and where they may have disappeared from the supply chain. By strengthening oversight from distribution to delivery, the government aims to protect public medicines and ensure that supplies reach the people for whom they were intended.

A key feature of the new system is the role it gives ordinary citizens in identifying suspected stolen government medicines. Members of the public are being urged to check security labels before purchasing medicines from pharmacies, drug stores and informal markets. Under the announced rules, a medicine carrying a red label marked “Property of the Ministry of Health, Not for Sale” should not be offered for commercial sale. Anyone who encounters such a product on sale is encouraged not to buy it and to report the matter to ZAMRA, the nearest health facility, the Drug Enforcement Commission or the Zambia Police. Public awareness will be important because the system’s effectiveness will depend not only on official inspections but also on people recognising suspicious products and reporting them to the appropriate authorities.

The government has also indicated that the security labels will support efforts to protect consumers from counterfeit and potentially unsafe medicines. Members of the public will be able to scan the labels using a free mobile application to check whether a medicine is genuine and safe to use. The barcode and serial number are intended to help users verify product information and identify packs that may require further investigation. This feature could be especially useful in situations where buyers have limited information about a medicine’s origin or supply history. However, consumers should continue to obtain medicines from authorised outlets and follow the advice of qualified healthcare professionals, since checking a label should complement rather than replace appropriate medical guidance.

The track and trace system is also intended to improve investigations into medicine theft by creating a clearer record of each product’s movement. When a pack is reported missing or discovered in an unauthorised location, its identifying information could help authorities establish where it entered the supply chain and where it was supposed to be delivered. This would give investigators a stronger basis for examining possible diversion from government warehouses, distribution points or health facilities. The system may also help identify patterns of suspicious activity involving repeated losses or medicines appearing in places where they should not be sold. By making individual packs easier to trace, the government aims to close gaps that have allowed public medicines to enter unauthorised markets.

The government has warned that anyone found stealing, purchasing or selling government medicines, or dealing in counterfeit security labels, will face investigation by the Drug Enforcement Commission and the Zambia Police. Those found responsible may be prosecuted in accordance with the applicable law. Pharmacies found stocking government medicines intended for free distribution through public health facilities also risk having their licences revoked and their premises closed. These measures are intended to discourage illegal trading and make it clear that public medicines cannot lawfully be diverted for private profit. Effective enforcement will be essential to ensure that the new requirements lead to real changes in how medicines are handled, distributed and sold across the country.

The implementation schedule gives medicine suppliers and other stakeholders time to prepare for the new requirements. The system takes effect on 2 November 2026, with a grace period running until 30 April 2027. From 1 May 2027, no medicine without a valid security label will be permitted anywhere in Zambia under the announced rules. This transition period is expected to give the relevant parties time to adapt their operations and comply with the new labelling requirements. Minister of Health Professor Roma Chilengi has stated that there will be no exceptions and no extension, signalling the government’s intention to enforce the deadline strictly.

The success of the initiative will depend on effective coordination between the Ministry of Health, ZAMRA, law enforcement agencies, medicine suppliers, pharmacies and healthcare facilities. These institutions will need to ensure that medicines receive the correct labels, tracking information remains reliable and suspected cases of theft are investigated promptly. Health workers and pharmacy operators will also need to understand the requirements so they can recognise improperly labelled products and respond appropriately. Public education will be equally important, particularly in helping consumers understand the difference between red and blue labels and how to report suspected illegal sales. The free mobile application could provide another layer of protection, provided that the public can access it easily and understand the results it provides.

Zambia’s national medicine track and trace system represents a significant step towards protecting public medicines, strengthening supply chain accountability and improving patient safety. By assigning unique identifiers to medicine packs and introducing clear security labels, the government aims to make theft and illegal resale easier to detect. The initiative also gives citizens a practical role in identifying suspected stolen medicines and alerting the authorities. Its long-term impact will depend on consistent enforcement, reliable tracking technology and cooperation across the healthcare sector. As the implementation deadline approaches, the message to the public and medicine suppliers is clear: government medicines are intended for patients who depend on public health services, not for illegal commercial sale, and suspected cases of diversion should be reported immediately.

Share This Article